The Latest: FDA posts early positive review of Pfizer data
WASHINGTON — U.S. health regulators say in their initial review that the vaccine from Pfizer is 95% protective against COVID-19.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
